Abstract
This chapter focuses on hantaviruses of known human health importance. In humans, New World hantaviruses cause hantavirus pulmonary syndrome (HPS) and Old World hantaviruses cause hemorrhagic fever with renal syndrome (HFRS). Hantaviruses are distributed world-wide and are maintained primarily in rodent hosts.
Rodent hosts are persistently infected, transmitting the viruses among themselves, through fighting or contamination of their surroundings, the latter being the most frequent source of human infection. A variety of ecological factors influence the population dynamics of these rodent hosts and, in turn, the dynamics of transmission among them with corresponding risk of human infection.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Background
Hantaviruses and their diseases have interesting histories. These viruses are distributed nearly world-wide and are maintained primarily in rodent hosts (Fig. 4.1). An increasing number of hantaviruses have recently been discovered in association with insectivore (order Soricomorpha) species, but none have been associated with human disease and they will not be discussed here. The hantaviruses of the Old World cause hemorrhagic fever with renal syndrome (HFRS) (Tables 4.1). Hantaviruses are a cause of HFRS throughout much of Europe and Asia (Vapalahti et al. 2003). In 1934, a mild form of HFRS, much later found to be due to Puumala virus (PUUV), was reported in Finland. During World War II, Japanese troops in Manchuria succumbed to a more severe disease. Hantaan virus (HTNV) infections causing HFRS with a 10 % case fatality rate were first recognized in 1951 in United Nations troops in Korea, when the disease was termed Korean hemorrhagic fever (KHF). The disease doubtless occurred in Asia perhaps for centuries. From 1951 to 1954, approximately 3,200 troops developed KHF (Schmaljohn and Hjelle 1997). Fatality rates declined gradually, from 4.9 % in 1982 to 2.7 % in 1991, then to 1 % in 1995 through 2007 (Zhang et al. 2010). Many years after the clinical syndrome was recognized, HTNV was first isolated by Lee et al. (1982) and later propagated in cell culture (French et al. 1981).
The isolation of Dobrava virus from a yellow-necked mouse (Apodemus flavicollis) was reported in 1992 (Avsic-Zupanc et al. 1992). The isolation of Belgrade virus from a severe human case of HFRS was reported that same year (Gligic et al. 1992). Subsequently, these viruses were shown to be identical and the International Committee for Taxonomy of Viruses (ICTV 2013) designated the name as Dobrava-Belgrade virus (DOBV). Following the isolation of the virus, DOBV was shown to be widely distributed in Europe and eastward in Russia (Tables 4.1), with A. flavicollis as the main rodent host. DOBV was isolated from a sibling rodent species, Black Sea field mice (A. ponticus), in the Black sea region of European Russia (cited in Klempa et al. 2013). The Saarema isolate of DOBV was found in striped field mice (A. agrarius) in two Estonian islands (Plyusnin et al. 1997). A Central European DOBV also was isolated from a striped field mouse (Klempa et al. 2005) Other molecularly distinct DOBV isolates were made from striped field mice from the Kurkino region of Russia (Plyusnin et al. 1999) and from Slovakia (Sibold et al. 1999, 2001). Interestingly, in several European countries where both striped and yellow-necked mice are present in the same areas, their viruses in each are from distinct genetic lineages. Because of the difference in lineages, Klempa et al. (2013) proposed that DOBV be subdivided into four genotypes, Dobrava, Kurkino, Saaremaa and Sochi, based on phylogeny, rodent host reservoir species, geographical distribution and pathogenicity for humans (Tables 4.1). Although Saarema virus has been recognized as a separate species, Klempa et al. (2013) make a strong case for it being a genotype of Dobrava-Belgrade virus. Following the recognition of HFRS due to HTNV, milder cases of HFRS were recognized in Finland due the Saaremaa lineage of DOBV, somewhat more severe cases in central and eastern Europe due to DOBV and HFRS cases of intermediate severity in urban settings in Europe and Asia due to Seoul virus (SEOV).
SEOV was first isolated from urban brown rats (Rattus norvegicus) in Seoul, Korea and reported in 1982 (Lee et al. 1982). There was evidence of SEOV infections occurring previously in laboratory rats in medical institutions in Japan (Umenai et al. 1979, Lee et al. 1979, Lee et al. 1980). In China, HFRS caused by SEOV was first identified in humans in 1981 in the neighboring regions of Henan and Shanxi provinces along the Yellow River (Hang et al. 1982). It was subsequently isolated from rats of two other species, R. losea and R. confuscianus (Liu et al. 1984). SEOV is unusual with its wide geographic distribution because movement of its carrier host, the brown rat through international shipping. The virus occurs in brown rats in Asia, Africa, Europe, and the Americas (Cueto et al. 2008; Leduc et al. 1986). More than 15,000 cases of HFRS are estimated to occur yearly, with more than half of these in China (Song 1999).
New World hantavirus pulmonary syndrome (HPS) is sometimes called hantavirus cardiopulmonary syndrome (HCPS). In 1993, the first recognized cases of HPS occurred in the Four Corners area of the southwestern USA (where the states of Arizona, Colorado, New Mexico, and Utah are contiguous) leading to the identification of a new hantavirus named Sin Nombre virus (SNV) detected in the tissues of patients and in deermice (Peromyscus maniculatus) trapped near patient’s dwellings (Hjelle et al. 1994; Ksiazek et al. 1995; Nichol et al. 1993).
As of December 31, 2013, 637 cases of HPS had been reported in the United States (CDC 2014). Of these reported cases, 63 % were male, 37 % female with a mean age of 37 years and a range of 6 to 83 years (CDC 2014). The discovery of SNV was followed by studies throughout the Americas, with several viruses identified as etiological agents of HPS, along with their Cricetid rodent reservoir hosts (Tables 4.1).
There are two other hantaviruses in the Americas that cause HPS with some frequency. Andes virus (ANDV) is endemic in the Andean region of Argentina and Chile, where a small number of cases of hantavirus pulmonary syndrome (HPS) occur every year. It was first detected in southwest Argentina, in a family outbreak in 1995 in a rural area near El Bolsón, where two of three individuals who developed HPS died. Hantavirus RNA was extracted from frozen autopsy lung and liver tissues, and was identified as ANDV (Lopez et al. 1996). In early outbreaks in Argentina, ANDV was shown to be transmitted directly from one person to another but only when individuals are in close contact (Enria et al. 1996; Padula et al. 1998; Toro et al. 1998). In Chile, confirmed cases of ANDV HPS have occurred since 1995 with serological surveys having confirmed its presence from 30° 56′S to 53° 37′S (Toro et al. 1998; Torres-Pérez et al. 2004). However, ANDV has been found in the long-tailed pygmy rice rat, its natural rodent host, throughout the animal’s range in Chile and in the Valdivian temperate forests in Argentina (Palma et al. 2012).
Cases of HPS also occur with some frequency in the Azuero Peninsula of Panama. The cases were first diagnosed in 1999. Subsequent studies found that the Costa Rican pygmy rice rat, Oligoryzomys fulvescens costaricensis, was the host of a novel hantavirus, Choclo virus, that was related to the cases of human HPS (Vincent et al. 2000). In a study in four western Panama clinics, individuals presenting with a severe febrile prodrome for acute hantavirus infection from 2006 to 2009, at least 21 % of 117 patients diagnosed with acute hantavirus infection had no evidence of pulmonary edema (without respiratory distress or radiographic lung infiltrates), and 44 % of patients had very mild HPS (radiographic pulmonary edema but no respiratory insufficiency). Thus, acute hantavirus infection caused by Choclo virus in Panama often occurs without severe HPS (Armien et al. 2013). However, there have been occasional cases of clinically severe HPS up to the present time.
Other hantaviruses have been shown to cause sporadic cases of HPS in the Americas (Tables 4.1). Studies of HPS cases and their epidemiologies in the Western Hemisphere are continuing.
2 Viruses
Hantaviruses are a genus within the family Bunyaviridae (Schmaljohn and Dalrymple 1983; Schmaljohn et al. 1983, 1985). The genus Hantavirus contains the only bunyaviruses that are not arthropod transmitted. Hantaviruses are enveloped, negative sense, with RNA in three segments designated as L (large, 6,530–6,550 nucleotides), M (medium, 3,613–3,707 nucleotides) and S (small, 1,696–2,083 nucleotides). The L segment codes for RNA-dependent RNA polymerase, the M segment for Gn and Gc envelope glycoproteins and the S segment for the nucleocapsid. The genome segments are encapsidated by the N protein to form ribonucleoproteins enclosed within a lipid envelope with glycoprotein spikes composed of Gn and Gc. The virion morphologically is round or pleomorphic with a diameter of 120–160 nm (Hepojoki et al. 2012). Electron microscopy shows that the virions have a grid like surface pattern unique to this genus (Martin et al. 1985). Unlike other genera of the Bunyaviridae, HTNV and SEOV do not have a nonstructural NSs protein (Schmaljohn et al. 1986). The viruses are inactivated by heat, organic solvents, detergents, ultraviolet irradiation, and hypochlorite solutions (Bi et al. 2008; Kraus et al. 2005). Reassortment between HTNV and SEOV tripartite genome segments was found in naturally infected brown rats in Guizhou Province, China (Zou et al. 2008), with S and M segments of two different lineages of DOBV (Klempa et al. 2003), and different lineages of PUUV in Finland (Razzauti et al. 2009), between different lineages of SNV (Rodriguez et al. 1998), which indicates that genetic reassortment can occur naturally between different hantaviruses or between lineages of the same hantavirus. The evolutionary radiation of selected hantaviruses and association with their rodent hosts is illustrated in Fig. 4.2.
3 Pathogenesis in Human Disease
The hantaviruses are responsible for human disease in the Western Hemisphere, Europe, and Asia. Both disease syndromes (HPS and HFRS) involve capillary leakage (Peters et al. 1999). There is evidence that pathogenesis is due to immunopathology, rather than direct cell and tissue damage (Borges et al. 2006; Kilpatrick et al. 2004; Terajima et al. 2004). It has been proposed (Terajima et al. 2007) that impairment of endothelial cells’ defense mechanisms against cytotoxic CD8+ T cells is the mechanism resulting in capillary leakage in HPS and HFRS. Tumor necrosis factor-α, interleukin-6 and -10 and γ-interferon play a role in pathogenesis (Makela et al. 2002; Mori et al. 1999). Studies of 21 HPS patients indicated that IL-6 may have an important role in the pathogenesis of HPS and was associated with fatal outcome. A mixed Th1/Th2 immune response occurred during the course of HPS and the magnitude of Th1 response effector cytokines was correlated to HPS severity. Reduced levels of TGF-beta in HPS patients suggested immunoregulatory damage (Borges et al. 2008).
Clinically, HPS is a severe disease with a case fatality rate of 36 % in the USA. The case definition of HPS (CDC 1997) is a febrile illness characterized by bilateral interstitial pulmonary infiltrates and respiratory compromise usually requiring supplemental oxygen and clinically resembling acute respiratory disease syndrome. Hematological and pulmonary histopathological features were described for a series of fatal HPS cases (Zaki et al. 1995). The incubation period is 1–5 weeks after exposure. Four to ten days after the initial phase of illness, coughing and shortness of breath may occur. The typical prodrome consists of fever, chills, myalgia, headache, and gastrointestinal symptoms with thrombocytopenia progressing rapidly to acute pulmonary edema, hypoxia, respiratory insufficiency, hypotension, and cardiogenic shock. There is hemoconcentration, left shift in the white blood cell count, neutrophilic leukocytosis, thrombocytopenia, and circulating immunoblasts. Because hypoxia induces pulmonary epithelial and endothelial cells to secrete vascular endothelial growth factor it can also increase capillary permeability and edema locally (Duchin et al. 1994; Gavrilovskaya et al. 2012). SNV-specific CD8(+) cells contribute to the severity of HPS disease outcome (Kilpatrick et al. 2004).
In general, HFRS symptoms usually develop 1–2 weeks after infection, but may take up to 8 weeks to appear. Initial symptoms begin suddenly and include intense headaches, back and abdominal pain, fever, chills, nausea, and blurred vision. There may be flushing of the face, inflammation or redness of the eyes, or a rash. Symptoms can progress, including low blood pressure, acute shock, vascular leakage, and acute kidney failure, which can cause severe fluid overload. The severity of the disease varies depending upon the virus causing the infection. Hantaan and Dobrava virus infections usually cause severe symptoms, while Seoul is intermediate, and Saaremaa and Puumala virus infections are usually more moderate (Plyusnin et al. 2006). Complete recovery may take months (CDC 2013b; Muranyi et al. 2005).
Nephropathia epidemica (NE) is a clinically milder form of HFRS. There is sudden onset with high fever, headache, backache, abdominal pain, and transient thrombocytopenia in the early phase of the disease. Three days later, there may be conjunctival hemorrhages and palatine and truncal petechiae. Usually, only 1 % of patients develop severe neurologic signs including seizures or bladder paralysis. Hemorrhages develop with oliguria, azotemia, proteinuria, and hematuria. The rash disappears after the third day and polyuria develops. The convalescent phase lasts for several weeks, usually without sequelae. Fatality from acute renal failure ranges from 0.1 to 1 % (Beers and Berkow 2005). Patients with neurological disease were seen in a large study of HFRS patients infected by Puumala virus. The common symptoms included headache, blurred vision, and vomiting and some of the patients had all three. Nine patients had severe neurological manifestations: meningism and cerebral hemorrhage during the first week of illness, and epileptiform seizures and urinary bladder paralysis during the second week (Alexeyev and Morozov 1995). Impaired pulmonary function has been documented in some HFRS patients (Linderholm et al. 1997; Mustonen et al. 1996) and more than half of 70 PUUV-infected, hospitalized patients had abnormal cardiac findings (Makela et al. 2009). However, one patient with Puumala virus infection who developed a severe clinical syndrome typical of hantavirus pulmonary syndrome (Gizzi et al. 2013).
Severe HFRS disease occurs in 10–15 % of cases. HFRS involves capillaries and venules, causing hemorrhage circulation disorders. Acute renal failure may result from interstitial hemorrhage and infiltrates (Sirotin and Keiser 2001).
The clinical course of severe HFRS has five phases: febrile, hypotensive, oliguric, diuretic, and convalescent. The onset lasts for 3–4 days with high fever, backache, abdominal pain, chills, myalgia, malaise, and bradycardia. Photophobia, pharynx enanthema, and a diffuse flushing of the face occur. Petechia develop on the palate and conjunctival hemorrhages may appear with temporary vision impairment. There is hematuria with gross proteinuria. Hypotension occurs 3–6 days after onset of fever and there may be shock. Laboratory findings include leukocytosis and thrombocytopenia. Renal damage occurs, including acute tubulointerstitial nephritis, necrotizing glomerulonephritis, and IgA nephropathy (Cosgriff 1991). The oliguric phase starts and hemorrhage may become severe. The diuretic phase usually begins on day 11. Convalescence usually begins 3 weeks to 6 months after the acute phase. Sequelae are unusual, but when they occur may include hypertension and chronic renal failure (Beers and Berkow 2005).
4 Zoonotic Hantaviruses and Their Rodent Hosts
Hantaviruses establish persistent infection in their rodent hosts without apparent disease (Botten et al. 2000, 2002). Studies suggest that TGF-β1-expressing regulatory T cells may play an important role in limiting immunopathology in the natural reservoir host, but may interfere with viral clearance (Schountz et al. 2007). This response may have arisen as a mutually beneficial, coadaptive, evolutionary process between hantaviruses and their natural rodent reservoirs, limiting disease from the infection while allowing virus persistence (Schountz et al. 2007). Perhaps there has been historic host switching followed by long-term adaptation (Ramsden et al. 2009), with persistent infections and minimal host damage. However, that strict concept has been challenged with new information indicating that host switching can occur currently (Lin et al. 2012; Vapalahti et al. 1996).
Natural and human-induced environmental changes can affect the prevalence and transmission of hantaviruses among their rodent hosts and spillover of the viruses to humans. It has been suggested that regulators of hantavirus prevalence and transmission can be categorized into five major classes (Mills 2005). (1) Environmental regulators (weather and food availability) affect transmission rates through their effect on reproductive success and on population densities. (2) Anthropogenic factors, such as ecosystem disturbance, may simplify those systems, decreasing biodiversity and favoring opportunistic species that may be hantavirus reservoirs. (3) Genetic factors may influence susceptibility of mice to infection or for chronic shedding. (4) Behavior, such as fighting, can increase risk of hantavirus transmission, causing different patterns of infection between males and females. In temperate regions, communal nesting may result in overwinter transmission. (5) Physiologic factors can control host response to infection and length of time the host remains infectious. Thus, risk prediction is difficult because these several regulators often interact. The relative importance of each factor varies according to the status of the host species, season, year, and geographic location.
There is evidence that regulators 1 and 2 above may be interacting synergistically to produce counterintuitive effects on the incidence of HPS. Although high biodiversity has been associated with high risk of emergence of infectious diseases (Jones et al. 2008; Wolfe et al. 2005), outbreaks of HPS and of the rodent borne viral hemorrhagic fevers have been associated with areas with severe anthropogenic disturbance and extremely low biodiversity (Mills 2006). There are several possible explanations for this apparent paradox.
Anthropogenic disturbance is known to simplify natural ecosystems, decreasing biodiversity and resulting in local extirpation of some species. As a result of global climate change, which is increasingly blamed on human factors (Stocker and Qin 2013), numerous species, including rodent hosts of zoonotic diseases, are moving their ranges poleward and upward in altitude (Hickling et al. 2006; Jannett et al. 2007; Moritz et al. 2008). Although a similar migration occurred at the end of the last ice age (Wright et al. 1993); migration is now complicated by massive barriers created through mechanized agriculture, massive deforestation, building of towns and cities and highways. Many species, especially nonvolant specialists, will not be able to migrate (Root and Schneider 2002). The Intergovernmental Panel on Climate Change (IPCC IV) predicts that 20–30 % of species are likely to at increased risk of extinction as global average temperature exceeds 1.5–2.5 °C above pre-industrial levels. Species, however, will not go extinct randomly. Specialist species with narrow habitat and diet requirements will disappear quickly, while more adaptable opportunistic species take their place, rapidly reproducing to high population densities in the absence of their specialist competitors (Dahlberg 1992; Peters 1997; Ruedas et al. 2004). Although opportunistic species constitute a minority of total Cricetid species, they form the majority of known hantavirus hosts in the Americas. Thus, climate change and anthropogenic disturbance may be acting synergistically to create conditions where opportunistic hosts of hantaviruses thrive, increasing risk to humans inhabiting those disturbed habitats.
A phenomenon labeled the “dilution effect” is hypothesized to result in higher risk of vector-borne (Ostfeld and Keesing 2000) and, apparently, directly transmitted zoonotic diseases including HPS (Clay et al. 2009; Mills 2006; Suzan et al. 2009) to humans in ecosystems with lower potential host diversity. Studies of the dilution effect are providing increasing evidence that human perturbation of ecosystems in the form of direct disturbance and indirectly through climate change are resulting in biodiversity loss which leads to greater incidence of HPS and other zoonotic diseases.
4.1 The Old World Zoonotic Hantaviruses and Their Rodent Hosts
Three hantaviruses in Europe, Dobrava, Seoul, and Puumala viruses, cause HFRS (Olsson et al. 2010).
4.1.1 Hantaan Virus (HTNV)
HTNV and its Asian variants are harbored in mice of the genus Apodemus (Lee et al. 1978a, b, 1981a, b). The reservoir of HTNV is A. agrarius koreae in eastern Asia including China. In China, the density of A. agrarius, the water-level difference in the Huai River and crop production were correlated with the incidence of HFRS (Bi et al. 1998). In another study employing a landscape epidemiologic approach, along with geographic information system and remote sensing techniques, multivariate logistic regression analysis showed that incidence of HFRS from HTNV infection was associated with elevation, a vegetation index, precipitation, annual cumulative air temperature, semihydromorphic soils, timber forests, and orchards (Yan et al. 2007). In farming areas of the Anhui Province of China, where cases of HFRS occurred, there was higher risk of HTNV infection among those who had slept on the ground or had been engaged in heavy farm work (Xu et al. 1985; Chen et al. 1986). HTNV variants Amur and Soochong viruses, both human pathogens, are harbored by A. peninsulae (Baek et al. 2006; Zhang et al. 2007). In laboratory studies, laboratory rats (R. norvegicus) infected with HTNV shed virus in saliva and feces but longest in urine (Lee et al. 1981a). A study of HFRS related hantaviruses in the Russian Far East has shown the presence of several different genotypes of viruses related to, but with S segments somewhat different from, HTNV (Yashina et al. 2000).
4.1.2 Puumala Virus (PUUV)
The bank vole Myodes glareolus, the reservoir host of PUUV is widely distributed in northern and central continental Europe (Bernshtein et al. 1999; Brummer-Korvenkontio et al. 1980). As with SNV in deer mice, PUUV infection in adults is associated with wounds in the fall, i.e., at the end of the breeding season, but not in spring. In addition, in a study in southern Belgium, sexually active animals were significantly more often wounded and positive for infection. Wounds resulting from biting or scratching were observed mainly in adult rodents. PUUV infection was associated with higher mobility in juvenile and subadult males (Escutenaire et al. 2002).
HFRS epidemics due to PUUV can be predicted based on the population dynamics of bank voles, the reservoir hosts (Kallio et al. 2009; Olsson et al. 2009). A recently developed model (Sauvage et al. 2007) indicated that only vole populations with multi-annual fluctuations resulted in simultaneously high numbers of infected voles with a high proportion of voles in the acute virus excretion phase as the population increase was ending. This results in a brief peak of exceptionally high virus concentrations in the environment with an increased risk of human exposure. In assessing factors influencing the association of increased PUUV infection in bank voles in a northern Sweden area endemic for the virus, four factors together predicted 80 % of the model outcome: age, body mass index, population abundance (increasing, peak, or declining/low), and sex. Specifically, voles that were in the oldest age class, of higher body mass index, in the peak stage of abundance and of male sex were most likely to be infected (Olsson et al. 2002). In this area in northern Sweden, particular environmental characteristics associated with old-growth moist forests dominated by Alectoria spp., Picea abies, fallen wood, and Vaccinium myrtillus were associated with increased bank vole abundance and, hence, the number of PUUV-infected voles, whereas dry forests did not have this association (Olsson et al. 2005).
Efficient spread and transmission of PUUV depends on high bank vole population densities that increase as food availability becomes abundant during good mast (edible shrub and tree seeds or nuts) years in central Europe (Schwarz et al. 2009; Tersago et al. 2009). Climate change can affect hantavirus occurrence in rodent hosts and risk of human PUUV infection. Climatic conditions favoring increased mast production have resulted in an increase in HFRS cases a year later (Clement et al. 2009). Increased average temperatures in West-Central Europe have been associated with more frequent PUUV outbreaks with increased bank vole population densities due to increased mast production. Warmer climate, perhaps coupled with increased surveillance, have resulted in an increase in documented cases of HFRS from PUUV infections (Heyman et al. 2009; Schwarz et al. 2009). In contrast, warm winters in Scandinavia have led to a decline in vole populations as a result of reduced protective snow cover with increased predation (Klempa 2009). Similar to findings with deermice and SNV discussed below, a study of wild populations of bank voles in Finland showed that PUUV infected voles had significantly lower overwinter survival (Kallio et al. 2007), slowed maturation, and reduced survival and reproduction compared to uninfected voles (Tersago et al. 2012).
4.1.3 Dobrava-Belgrade Virus (DOBV)
DOBV is a genetically distinct hantavirus (Xiao et al. 1993). In Europe, Apodemus flavicollis, the yellow-necked forest mouse is the reservoir species of DOBV (Avsic-Zupanc et al. 1992; Taller et al. 1993). Sequence comparison and phylogenetic analysis of the Slovenian wild type DOBV from A. flavicollis strains were closely related whereas the strain harbored by A. agrarius had a high level of genetic diversity from other Slovenian DOBV strains and clustered together on phylogenetic trees with other DOBV strains harbored by A. agrarius from Russia, Estonia, and Slovakia. These findings suggest that the DOBV variants harbored by the two species of Apodemus in Europe represent distinct genetic lineages (Avsic-Zupanc et al. 2000). DOBV was recently reported to occur in A. uralensis captured on the Black Sea coast of Turkey (Oktem et al. 2014).
4.1.4 Seoul Virus (SEOV)
The brown rat (Rattus norvegicus) is the main reservoir host of SEOV and is doubtless responsible for moving it around the world. Lin et al. (2012) hypothesized that an ancestor of phylo-group A SEOV variants was first exported from China to Europe and then spread through the New World following the migration of brown rats. Phylogenetic analysis carried out by these authors that included 136 novel Chinese strains, indicated existence of four distinct phylogroups. All non-Chinese SEOV strains and most of the Chinese variants fell into the phylogroup A, while the Chinese strains originating from mountainous areas clustered into three other distinct groups (B, C, and D).
SEOV has also been isolated from wild (Lee et al. 1982) and domestic pet Rattus rattus (Jameson et al. 2013). SEOV variants Geo and Serang viruses are associated with R. rattus in China and R. tanezumi in Indonesia respectively (Leduc 1987; Plyusnin et al. 2009). Transmission between brown rats can occur through exposure to SEOV-containing excrement or by wounds inflicted through fighting (Glass et al. 1988; Hinson et al. 2004). Infection of newborn laboratory R. norvegicus resulted in persistent infection, but infection was transitory when adult rats were infected (Kariwa et al. 1996). SEOV was detected in pet rats (R. norvegicus) in England (Jameson et al. 2013) and in Sweden (Lundkvist et al. 2013) with a risk of human infection to humans in contact with these pets.
4.2 The New World Zoonotic Hantaviruses and Their Rodent Hosts
HPS due to SNV infection was first recognized in 1993 in the Four Corners area of the USA. SNV was shown to be harbored by the North American deermouse, Peromyscus maniculatus, a species widely distributed in North America that occurs in a variety of habitats (Childs et al. 1994; Nichol et al. 1993). Subsequently, presence of SNV antibody indicated that deermice were infected throughout their range in the United States, Canada, and Mexico (Mills et al. 1998; Monroe et al. 1999). Studies during the initial outbreak indicated that cases clustered seasonally and temporally by biome type and geographic location. Areas of human exposure and areas of highest prevalence in host populations were most often found in pinyon-juniper woodlands, grasslands, and Great Basin desert scrub lands, at elevations of 1,800–2,500 m (Engelthaler et al. 1999; Mills et al. 1997). Elevation, as well as habitat evaluation accrued from satellite data, showed an association between environmental conditions and HPS risk the following year (Glass et al. 2000). It was hypothesized that the 1991–1992 El Niño-southern oscillation (ENSO) caused increased precipitation, increasing the food supply that led to greater rodent population densities with enhanced risk of transmission to humans. The result of this series of events may have been responsible for the 1993–1994 outbreak of the disease in the Four Corners states. A second strong ENSO occurred in 1997–1998. Researchers who were monitoring rainfall, habitat quality, and deermouse population density in the southwestern US at the time observed increased rainfall, green-up of vegetation, increased food supplies, and an abrupt spike in deermouse population density. The peak in rodent density was followed by a similar peak in HPS cases in the Four Corners states in 1998–1999 (Mills 2005; Yates et al. 2002). Most of the 1998–1999 patients reported indoor exposure to deermice (Hjelle and Glass 2000). Several of the initial (1993) cases in the Four Corners area occurred in Native Americans. Interestingly, the oral history of local American Indian healers describes clusters of similar deaths occurring over three cycles during the twentieth century in association with specific ecological changes (Chapman and Khabbaz 1994).
Subsequent field studies indicated that SNV occurred in an extensive geographic area where P. maniculatus is found. However, infections in deermouse populations were focal, being common in some areas and absent in others. Areas of high SNV antibody prevalence in deermouse populations were determined and satellite imagery was used to identify environmental characteristics associated with transmission within its reservoir population. At least 2 years of high-risk conditions were needed for prevalence to increase. Areas with persistently high-risk environmental conditions may serve as maintenance foci for the survival of SNV in local deermouse populations (Glass et al. 2002). Despite very low rodent population densities at some sites, hantavirus infection persisted at a low level, perhaps because of chronic infection and shedding in a few long-lived individuals or by periodic virus reintroduction from neighboring populations. Hantavirus antibody prevalence was seasonal with multiyear patterns suggesting a delayed density-dependent relationship between prevalence and population density (Mills et al. 1999). SNV infection was more prevalent in males and individuals of larger body mass (Douglass et al. 2001; Mills et al. 1997). In deermice, IgG antibody prevalence was positively associated with delayed population density. Virus transmission among deermice, as indicated by seroconversion, occurred primarily during the breeding season (spring through summer) and primarily affected males (Douglass et al. 2007). In some sites, there was a second peak in the in the winter that affected males and females equally (Calisher et al. 1999). This might be explained in that breeding season transmission may involve male-to-male aggression while mid-winter transmission may be associated with communal huddling that involves both sexes. Serological results suggested that the longer deermice live, the greater the probability they will be infected with SNV (Calisher et al. 1999). At numerous sites in the southwestern US, SNV antibody prevalence in deermice was inversely correlated with rodent species richness (number of species) and diversity (a measure combining richness and proportional representation of species) (Calisher et al. 2002; Clay et al. 2009; Mills 2006).
Higher prevalence of SNV infections in male deermice related to virus transmission from aggression was demonstrated in several studies. In longitudinal studies in Colorado and Montana, there was a positive association between wounds and SNV antibody in adult deermice suggesting that when infected rodents fight with uninfected individuals, virus transmission occurs (Calisher et al. 1999; Douglass et al. 2001). As in other studies, male rodents comprised a larger percentage of the total seropositive mice suggesting that male mice contribute more to the SNV epizootic cycle than female mice.
Antibody prevalence and occurrence of SNV RNA in blood have been used as indications of presence of SNV in deermouse populations. However, the antibody response to SNV infection in naturally infected deermice was shown to be highly variable. Presence of SNV RNA has been used as an indicator of relative risk of transmission. Blood levels of viral RNA varied as much as 100-fold, even in individuals infected with identical strains of virus. Deermice that infected other susceptible individuals tended to have a higher SNV RNA levels than those that did not infect other individuals (Bagamian et al. 2012).
Although hantavirus infections have been considered to have little adverse effect on their natural rodent hosts, a field study in Montana showed that recently infected male deermice gained less weight over the 1-month period following seroconversion than did those that did not acquire antibody, suggesting that SNV infection may have negatively impacted the health of infected individuals (Douglass et al. 2007) and decreased survival time (Luis et al. 2012). SNV infected deermice had smaller movement areas on trapping grids than uninfected individuals (Amman et al. 2013), another effect that can influence population dynamics and the maintenance of the virus in nature.
The ecological setting can influence the prevalence of SNV infections in deer mice populations. Studies of SNV infections in P. maniculatus populations in California and Nevada characterized the vegetation type and density, elevation, slope, and hydrologic features of study sites using remote sensing and geographic information systems data. The data retroactively predicted infection status of deermice with up to 80 % accuracy (Boone et al. 2000), with potential use as a determinant of risk of human infection.
Numerous other rodents of the families Cricetidae, Muridae, and even Sciuridae (squirrels) have been occasionally found with antibody to SNV, or even SNV RNA, as a result of spillover infection, especially during periods of very high deermouse population density (Childs et al. 1994). It is likely that similar spillover occurs for all hantaviruses and such events in the past may have led to host-switching, coadaptation and the evolution of new hantaviral lineages.
Among the New World hantaviruses, SNV epidemiology is the best studied. After its discovery, other hantaviruses that cause HPS were discovered in various areas of North, Central and South America (Tables 4.1). At least 13 named hantavirus genotypes have been described in 12 species of rodent hosts of the family Cricetidae, subfamily Sigmodontinae (New World rats and mice) in the four countries of the Southern Cone of South America (Palma et al. 2012).
Andes virus is endemic in the Andean region of Chile and Argentina. Andes virus HPS in Chile and Argentina occurs where there is contact with the pygmy rice rat (Oligoryzomys longicaudatus) and its habitat in rural areas. The habitat is characterized by shrub vegetation, and forest edge with bamboo (colihue cane, Chusquea quila) and brushy peridomestic areas. Population irruptions of these rodents can occur when colihue cane flowers, producing seeds that are a preferred source of food for them (Palma et al. 2012). Population densities of these rodents during population irruptions may reach as much as 100 individuals per ha (Jimenez et al. 1992; Gallardo and Mercado 1999). Interestingly, ANDV antibody prevalence in the long-tailed pygmy rice rats was seasonally highest in the spring, when the population was comprised mainly of adults, than in the autumn, when the populations, although of higher densities, consisted mainly of juvenile individuals. The highest relative seroprevalence of O. longicaudatus was found in the Mediterranean ecoregion. Torres-Pérez et al. (2010) postulated that spatial features such as landscape structure and habitat fragmentation are major components in differences in ANDV antibody prevalence in this rodent in Chile. This relationship suggests delayed density dependent effects on antibody prevalence (Mills et al. 2007). The peridomestic habitat places them in close juxtaposition with human dwellings.
In Panama, cases of HPS occur in the Azuero Peninsula where contact with the Costa Rican pygmy rice rat (Oligoryzomys fulvescens costaricensis), the host of Choclo virus, and its habitat occur. This rodent is found in anthropogenically disturbed habitats characterized by several crops including corn (maze), watermelon, beans, coffee and sugar cane (Salazar-Bravo et al. 2004).
Other hantaviruses associated with human disease in North, Central, and South America are listed in Table 4.1. The rodent hosts for most of these hantaviruses have been identified, although there is incomplete understanding of host and virus taxonomy.
5 Transmission to Humans
Risk of transmission to humans usually depends on presence of viable virus in the environment. Several hantaviruses have been shown to be relatively stable under environmental conditions. Transmission of hantaviruses to humans most frequently occurs through breathing of aerosols of virus-contaminated rodent excreta with exposure often occurring when entering or cleaning rodent-infested structures (Armstrong et al. 1995). Large quantities of infectious virus may be excreted in the urine, saliva, and feces of the infected rodents. Voles infected with PUUV have shown that the shed virus is surprisingly stable, and thereby infectious over long periods outside the rodent host (Kallio et al. 2006). In laboratory studies, cell-cultured HTNV on glass or plastic surfaces remained infectious for 1–3 days at room temperature (Schmaljohn et al. 1998). Similar laboratory experiments with dried PUUV from cell culture gave similar results with all virus becoming noninfectious after 24 h. In contrast, naïve bank voles that were exposed to bedding (wood shavings) contaminated by laboratory infected “donor” voles became infected when exposed to the contaminated bedding up to 15 days after the donor voles had been removed (Kallio et al. 2006). In cotton rats (Sigmodon hispidus) infected experimentally with Black Creek Canal virus, virus was sporadically isolated from wet bedding and consistently from dried feces, strongly suggesting that the virus was somewhat stable in the environment (Hutchinson et al. 1998).
These experiments were conducted in the laboratory environment. Exposure to sunlight would likely have rendered the virus noninfectious in a few hours, if not minutes. Virus may be shed by infected hosts at least intermittently for the life of the rodent. The quantity of virus shed may be orders of magnitude higher during the first 2–8 weeks following infection (Lee et al. 1981a; Hutchinson et al. 1998). Peak shedding of PUUV occurred at 11–28, 14–21, and 11–28 days postinfection for saliva, urine, and feces, respectively (Hardestam et al. 2008).
6 Diagnosis and Treatment of Hantavirus Infections
6.1 Diagnosis
Clinically, the patterns of symptoms, the rate of development of signs and symptoms, and specific clinical laboratory parameters discriminated between individuals having SNV infections and developing HPS versus those suspected of having the infections but later were ruled out (Chapman et al. 1999).
Laboratory diagnosis can be made by serology (detection of immunoglobulin M or rising titers of immunoglobulin G or A) (Padula et al. 2000), by demonstration of hantavirus-specific RNA by polymerase chain reaction (PCR) (Giebel et al. 1990) or of hantavirus antigens by immunohistochemistry (CDC 1997). The requirement for a high level of biological containment for infectious hantaviruses has been a significant constraint in the development of serological diagnostic tests. Use of an expression vector for the nucleocapsid protein gene of provided specific serological reactivity with immune sera (Schmaljohn et al. 1983). The low level of biological containment required for production of this protein offers a significant advantage over live virus antigens for serological diagnosis of hantavirus infections. As a field test, a strip immunoblot assay bearing four immobilized antigens for SNV showed promise for the detection of SNV antibodies early in the course of HPS (Hjelle et al. 1997). Presumptive diagnosis may be made by examination of a peripheral blood smear after the onset of the cardiopulmonary phase of HPS (Mertz et al. 2006). A rapid and easy test for PUUV and ANDV employed an immunochromatographic assay and was useful for the diagnosis of nephrophathy from PUUV infection in Europe. Recently, multiparametric indirect immunofluorescence assays (IFA) based on biochip mosaics were developed to detect serum antibodies against clinically important Old and New World hantaviruses simultaneously. The multiparametric IFA provided highly sensitive and specific serological diagnosis of HTNV, PUUV, SEOV, SAAV, DOBV, SNV or ANDV (Lederer et al. 2013). With both human and animal sera, antibody responses fell into two groups: those that reacted with HTNV, SEOV, and DOBV and those reacting with SNV and PUUV (Elgh et al. 1997).
A real-time reverse transcriptase (RT) PCR method developed for detection of PUUV RNA had a detection threshold for PUUV cDNA of two copies per reaction. A two-step qualitative RT-PCR to detect PUUV RNA showed 100 % agreement with the real-time RT-PCR assay (Evander et al. 2007).
6.2 Treatment
Critical care management for HPS includes the avoidance of fluid overload and cardiac output maintained. In severe SNV infections, patients experience extreme pulmonary edema and cardiogenic shock and may require mechanical ventilation and occasionally extracorporeal membrane oxygenation therapy (Koster and Jenison 1997). About 5 % of hospitalized PUUV and 16–48 % of DOBV patients require dialysis and prolonged intensive-care treatment (Vaheri et al. 2013).
Treatment with intravenous ribavirin is probably not effective when initiated during the cardiopulmonary phase of HPS (Mertz et al. 2006). However, ribavirin has been used successfully to reduce mortality and the severity of disease in HFRS patients
6.3 Prevention and Control
Vaccines are used to prevent HTNV infections in Asia. To control and prevent HFRS in China, a comprehensive preventive strategy has been implemented and includes public health education and promotion, rodent control, surveillance, and vaccination (Zhang et al. 2010). Approximately two million doses of inactivated rodent brain- or cell culture-derived HFRS vaccines are given annually in China. Although vaccination, along with public education and rodent control measures, have coincided with a reduction in HFRS cases to less than 20,000 per year, China still has the highest number of HFRS cases and deaths in the world (Zhang et al. 2010). A rodent brain-derived inactivated HFRS vaccine has also been used in the Republic of Korea since the early 1990s and has similarly resulted in reduced numbers of HFRS cases (Cho et al. 2002). This vaccine has been used in Korea for military personnel and high-risk rural residents (Cho and Howard 1999; Lee et al. 1990; Sohn et al. 2001). Schmaljohn et al. (1990) found that passively transferred neutralizing monoclonal antibodies prevented infection, suggesting that an antibody response alone can prevent infection.
There are no commercially available vaccines for New World hantaviruses. In experiments designed as a proof of concept, Rhesus macaques were vaccinated with an expression plasmid that contained HTNV and ANDV M genome segments (Custer et al. 2003). The animals developed high levels of neutralizing antibodies that not only neutralized ANDV but also cross-neutralized other HPS-associated hantaviruses, including SNV (Hooper et al. 2006). However, the high cost of development of commercial vaccines is prohibitive considering the relatively small number of HPS cases in the Americas.
Prevention is the best approach to avoid becoming infected with hantaviruses. Although the CDC recommendations are focused on North American hantaviruses, (CDC 2013a) the same measures apply to avoidance of hantavirus infection in other geographic areas. The CDC preventive measures, as well as those of most national and local health agencies include:
-
Eliminate or minimize contact with rodents in the house, workplace, or campsite.
-
Seal up holes and gaps in the house and garage.
-
Place traps in and around the house to decrease rodent infestation.
-
Eliminate available rodent food sources.
-
Ventilate closed areas that have been unoccupied for a long period of time that may be inhabited by rodents.
-
Avoid making dust. Wet down floors and other surfaces with bleach before sweeping.
-
Keep food and garbage in rodent-proof thick plastic or metal containers with tight lids.
-
Keep outside cooking areas and grills clean.
-
Put pet food away after use and do not leave pet-food out overnight.
-
Keep garbage in a rodent-proof thick plastic or metal garbage can with a tight lid.
-
Keep bird feeders away from the house and utilize squirrel guards to limit access to the feeder by rodents.
-
Keep compost bins as far away from the house as possible (30 m or more).
-
Keep grains and animal feed in rodent-proof thick plastic or metal containers with tight lids. In the evening, uneaten animal feed should be returned to containers with lids.
-
Eliminate possible rodent nesting sites outside the house. Elevate hay, woodpiles, and garbage cans at least 30 cm off the ground.
-
Move woodpiles far away from the house (30 m or more).
-
Get rid of old trucks, cars, and old tires that could house mice and rats.
-
Keep grass cut short and shrubbery within 30 m of the home well trimmed.
References
Alexeyev OA, Morozov VG (1995) Neurological manifestations of hemorrhagic fever with renal syndrome caused by Puumala virus: review of 811 cases. Clin Infect Dis 20(2):255–258
Amman BR, Manangan AP, Flietstra TD, Calisher CH, Carroll DS, Wagoner KD, Mills JN (2013) Association between movement and Sin Nombre virus (Bunyaviridae: Hantavirus) infection in North American deermice (Peromyscus maniculatus) in Colorado. J Wildl Dis 49(1):132–142
Armien B, Pascale JM, Muñoz C, Mariñas J, Núñez H, Herrera M, Trujillo J, Sánchez D, Mendoza Y, Hjelle B, Koster F (2013) Hantavirus fever without pulmonary syndrome in Panama. Am J Trop Med Hyg 89:489–494
Armstrong LR, Zaki SR, Goldoft MJ, Todd RL, Khan AS, Khabbaz RF, Ksiazek TG, Peters CJ (1995) Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures [letter]. J Infect Dis 172(4):1166
Avsic-Zupanc T, Xiao SY, Stojanovic R, Gligic A, Vandergroen G, Leduc JW (1992) Characterization of Dobrava virus: a hantavirus from Slovenia, Yugoslavia. J Med Virol 38:132–137
Avsic-Zupanc T, Nemirov K, Petrovec M, Trilar T, Poljak M, Vaheri A, Plyusnin A (2000) Genetic analysis of wild-type Dobrava hantavirus in Slovenia: co-existence of two distinct genetic lineages within the same natural focus. J Gen Virol 81(7):1747–1755
Baek LJ, Kariwa H, Lokugamage K, Yoshimatsu K, Arikawa J, Takashima I, Kang JI, Moon SS, Chung SY, Kim EJ et al (2006) Soochong virus: an antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea. J Med Virol 78(2):290–297
Bagamian KH, Towner JS, Kuenzi AJ, Douglass RJ, Rollin PE, Waller LA, Mills JN (2012) Transmission ecology of Sin Nombre hantavirus in naturally infected North American deermouse populations in outdoor enclosures. PLoS One 7(10):e47731
Beers MH, Berkow R (2005) Infectious diseases; viral diseases. The merck manual of diagnosis and therapy, 17th edn. Wiley, Indianapolis
Bernshtein AD, Apekina NS, Mikhailova TV, Myasnikov YA, Khlyap LA, Korotkov YS, Gavrilovskaya IN (1999) Dynamics of Puumala hantavirus infection in naturally infected bank voles (Clethrinomys glareolus). Arch Virol 144(12):2415–2428
Bi P, Wu X, Zhang F, Parton KA, Tong S (1998) Seasonal rainfall variability, the incidence of hemorrhagic fever with renal syndrome, and prediction of the disease in low-lying areas of China. Am J Epidemiol 148(3):276–281
Bi Z, Formenty PB, Roth CE (2008) Hantavirus infection: a review and global update. J Infect Dev Ctries 2(1):3–23
Boone JD, Mcgwire KC, Otteson EW, Debaca RS, Kuhn EA, Villard P, Brussard PF, St Jeor SC (2000) Remote sensing and geographic information systems: charting Sin Nombre virus infections in deer mice. Emerg Infect Dis 6(3):248–258
Borges AA, Campos GM, Moreli ML, Souza RL, Aquino VH, Saggioro FP, Figueiredo LT (2006) Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 8(8):2324–2330
Borges AA, Campos GM, Moreli ML, Moro Souza RL, Saggioro FP, Figueiredo GG, Livonesi MC, Moraes Figueiredo LT (2008) Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect 10(10–11):1150–1157
Botten J, Mirowsky K, Kusewitt D, Bharadwaj M, Yee J, Ricci R, Fedderson RM, Hjelle B (2000) Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci U S A Biol Sci 97(19):10578–10583
Botten J, Mirowsky K, Ye C, Gottlieb K, Saavedra M, Ponce L, Hjelle B (2002) Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model. J Virol 76(15):7587–7594
Brummer-Korvenkontio M, Vaheri A, Hovi T, Von Bonsdorff CH, Vuorimies J, Manni T, Penttinen K, Oker-Blom N, Lähdevirta J (1980) Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 141:131–134
Calisher CH, Sweeney W, Mills JN, Beaty BJ (1999) Natural history of Sin Nombre virus in western Colorado. Emerg Infect Dis 5(1):126–134
Calisher CH, Root JJ, Mills JN, Beaty BJ (2002) Assessment of ecologic and biologic factors leading to hantavirus pulmonary syndrome, Colorado, U.S.A. Croat Med J 43(3):330–337
CDC (1997) Case definitions for infectious conditions under public health surveillance. Centers for disease control and prevention. MMWR Recomm Rep 46(RR-10):1–55
CDC (2013a) Hantavirus. http://www.cdc.gov/hantavirus. Accessed 20 May 2013
CDC (2013b) Hemorrhagic fever with renal syndrome. http://www.cdc.gov/hantavirus/hfrs/index.html. Accessed 15 June 2013
CDC (2014) Reported cases of HPS. http://www.cdc.gov/hantavirus/surveillance/index.html. Accessed 14 August 2014
Chapman LE, Khabbaz RF (1994) Etiology and epidemiology of the Four Corners hantavirus outbreak. Infect Agents Dis 3(5):234–244
Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT et al (1999) Intravenous ribavirin for hantavirus pulmonary syndrome: a safety and tolerance during 1 year of open-label experience. Antivir Ther 4:211–219
Chen H-X, Qiu F-X, Dong B-J, Ji S-Z, Li Y-T, Wang Y et al (1986) Epiedmiologic studies on hemorrhagic fever with renal syndrome in China. J Infect Dis 154:394–398
Childs JE, Ksiazek TG, Spiropoulou CF, Krebs JW, Morzunov S, Maupin GO, Rollin PE, Sarisky J, Enscore RE, Frey JK et al (1994) Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 169:1271–1280
Cho HW, Howard CR (1999) Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 17(20–21):2569–2575
Cho HW, Howard CR, Lee HW (2002) Review of an inactivated vaccine against hantaviruses. Intervirology 45:328–333
Clay CA, Lehmer EM, St Jeor S, Dearing MD (2009) Sin Nombre virus and rodent species diversity: a test of the dilution and amplification hypotheses. PLoS One 4:e6467
Clement J, Vercauteren J, Verstraeten WW, Ducoffre G, Barrios JM, Vandamme AM, Maes P, Van RM (2009) Relating increasing hantavirus incidences to the changing climate: the mast connection. Int J Health Geogr 8:1
Cosgriff TM (1991) Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 13(1):97–107
Cruz CD, Forshey BM, Vallejo E, Agudo R, Vargas J, Blazes DL, Guevara C, Laguna-Torres VA, Halsey ES, Kochel TJ (2012) Novel strain of Andes virus associated with fatal human infection, central Bolivia. Emerg Infect Dis 18(5):750–757
Cueto GR, Cavia R, Bellomo C, Padula PJ, Suarez OV (2008) Prevalence of hantavirus infection in wild Rattus norvegicus and R. rattus populations of Buenos Aires City, Argentina. Trop Med Int Health 13(1):46–51
Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW (2003) Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77(18):9894–9905
Dahlberg KA (1992) The conservation of biological diversity and U.S. agriculture: goals, institutions, and policies. Agric Ecosyst Environ 42:177–193
Delfraro A, Clara M, Tome L, Achaval F, Levis S, Calderón GE, Enría D, Lozano M, Russi J, Arbiza J (2003) Yellow pygmy rice rat (Oligoryzomys flavescens) and hantavirus pulmonary syndrome in Uruguay. Emerg Infect Dis 9(7):846–852
Delfraro A, Tome L, D’elia G, Clara M, Achaval F, Russi JC, Rodonz JR (2008) Juquitiba-like hantavirus from 2 nonrelated rodent species, Uruguay. Emerg Infect Dis 14(9):1447–1451
Douglass RJ, Wilson T, Semmens WJ, Zanto SN, Bond CW, Van Horn RC, Mills JN (2001) Longitudinal studies of Sin Nombre virus in deer mouse dominated ecosystems of Montana. Am J Trop Med Hyg 65(1):33–41
Douglass RJ, Calisher CH, Wagoner KD, Mills JN (2007) Sin Nombre virus infection of deer mice in Montana: characteristics of newly infected mice, incidence, and temporal pattern of infection. J Wildl Dis 43(1):12–22
Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Rollin PE, Nichol S, Umland ET, Group HS (1994) Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. New Engl J Med 330:949–955
Elgh F, Lundkvist A, Alexeyev OA, Stenlund H, Vsic-Zupanc T, Hjelle B, Lee HW, Smith KJ, Vainionpaa R, Wiger D et al (1997) Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins to five viral serotypes. J Clin Microbiol 35(5):1122–1130
Elwell MR, Ward GS, Tingpalapong M, Leduc JW (1985) Serologic evidence of Hantaan-like virus in rodents and man in Thailand. Southeast Asian J Trop Med Public Health 16:349–354
Engelthaler DM, Mosley DG, Cheek JE, Levy CE, Komatsu KK, Ettestad P, Davis T, Tanda DT, Miller L, Frampton JW et al (1999) Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States. Emerg Infect Dis 5(1):87–94
Enria D, Padula P, Segura EL, Pini N, Edelstein A, Posse CR, Weissenbacher MC (1996) Hantavirus pulmonary syndrome in Argentina Possibility of person to person transmission. Medicina (B Aires) 56:709–711
Escutenaire S, Chalon P, De Jaegere F, Karelle-Bui L, Mees G, Brochier B, Rozenfeld F, Pastoret PP (2002) Behavioral, physiologic, and habitat influences on the dynamics of Puumala virus infection in bank voles (Clethrionomys glareolus). Emerg Infect Dis 8:930–936
Evander M, Eriksson I, Pettersson L, Juto P, Ahlm C, Olsson GE, Bucht G, Allard A (2007) Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 45(8):2491–2497
Firth C, Tokarz R, Simith DB, Nunes MR, Bhat M, Rosa ES, Medeiros DB, Palacios G, Vasconcelos PF, Lipkin WI (2012) Diversity and distribution of hantaviruses in South America. J Virol 86(24):13756–13766
French G, Foulke R, Brand O, Eddy G (1981) Korean hemorrhagic fever: propagation of the etiologic agent in a cell line of human origin. Science 211:1046–1048
Gallardo MH, Mercado CL (1999) Mast seeding of bamboo shrubs and mouse outbreaks in southern Chile. Mastozool Neotrop 6:103–111
Gavrilovskaya I, Gorbunova E, Koster F, Mackow E (2012) Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv Virol 2012:674360
Giebel LB, Zoller L, Bautz EKF, Darai G (1990) Rapid detection of genomic variations in different strains of hantaviruses by polymerase chain reaction techniques and nucleotide sequence analysis. Virus Res 16:127–136
Gizzi M, Delaere B, Weynand B, Clement J, Maes P, Vergote V, Laenen L, Hjelle B, Verroken A, Dive A, Michaux I, Evrard P, Creytens D (2013) Bulpa P (2013) Another case of “European hantavirus pulmonary syndrome” with severe lung, prior to kidney, involvement, and diagnosed by viral inclusions in lung macrophages. Eur J Clin Microbiol Infect Dis 32:1341–1345
Glass GE, Childs JE, Korch GW, Leduc JW (1988) Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus). Epidemiol Infect 101:459–472
Glass GE, Cheek JE, Patz JA, Shields TM, Doyle TJ, Thoroughman DA, Hunt DK, Enscore RE, Gage KL, Irland C et al (2000) Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. Emerg Infect Dis 6(3):238–247
Glass GE, Yates TL, Fine JB, Shields TM, Kendall JB, Hope AG, Parmenter CA, Peters CJ, Ksiazek TG, Li CS et al (2002) Satellite imagery characterizes local animal reservoir populations of Sin Nombre virus in the southwestern United States. Proc Natl Acad Sci U S A 99(26):16817–16822
Gligic A, Dimkovic N, Xiao SY, Buckle GJ, Jovanovic D, Velimirovic D, Stojanovic R, Obradovic M, Diglisic G, Micic J et al (1992) Belgrade virus: a new hantavirus causing severe hemorrhagic fever with renal syndrome in Yugoslavia. J Infect Dis 166:113–120
Hang CS, Song G, Qiu XZ, Du YL, Zhao JN, Liao HX et al (1982) Investigation of the agent causing mild type of hemorrhagic fever [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 3:204–205
Hardestam J, Karlsson M, Falk KI, Olsson G, Klingstrom J, Lundkvist A (2008) Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus). Emerg Infect Dis 14(8):1209–1215
Hepojoki J, Strandin T, Lankinen H, Vaheri A (2012) Hantavirus structure–molecular interactions behind the scene. J Gen Virol 93(Pt 8):1631–1644
Heyman P, Vaheri A, Lundkvist A, Vsic-Zupanc T (2009) Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther 7(2):205–217
Hickling R, Roy DB, Hill JK, Fox R, Thomas CD (2006) The distributions of a wide range of taxonomic groups are expanding polewards. Glob Change Biol 12(3):450–455
Hinson ER, Shone SM, Zink MC, Glass GE, Klein SL (2004) Wounding: the primary mode of Seoul virus transmission among male Norway rats. Am J Trop Med Hyg 70(3):310–317
Hjelle B, Glass GE (2000) Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997–1998 El Niño-Southern oscillation. J Infect Dis 181(5):1569–1573
Hjelle B, Jenison S, Torrez-Martinez N, Yamada T, Nolte K, Zumwalt R, Myers G (1994) A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J Virol 68:592–596
Hjelle B, Krolikowski J, Torrez-Martinez N, Chavez-Giles F, Vanner C, Laposata E (1995) Phylogenetically distinct hantavirus implicated in a case of hantavirus pulmonary syndrome in the northeastern United States. J Med Virol 46(1):21–27
Hjelle B, Torrez-Martinez N, Koster FT (1996) Hantavirus pulmonary syndrome-related virus from Bolivia [letter]. Lancet 347:57
Hjelle B, Jenison S, Torrez-Martinez N, Herring B, Quan S, Polito A, Pichuantes S, Yamada T, Morris C, Elgh F et al (1997) Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 35(3):600–608
Hooper JW, Custer DM, Smith J, Wahl-Jensen V (2006) Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 347(1):208–216
Hugot JP, Plyusnina A, Herbreteau V, Nemirov K, Laakkonen J, Lundkvist A, Supputthamongkol Y, Henttonen H, Plyusin A (2006) Genetic analysis of Thailand hantavirus in Bandicota indica trapped in Thailand. Virol J 3(72)
Hutchinson K, Rollin P, Peters CJ (1998) Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg 59:58–65
ICTV (2013) Virus taxonomy: 2012 release. http://ictvonline.org/virusTaxonomy.asp. Accessed 6 Apr 2013
Jameson LJ, Taori SK, Atkinson B, Levick P, Featherstone CA, Van Der Burgt G, Mccarthy N, Hart J, Osborne JC, Walsh AL et al (2013) Pet rats as a source of hantavirus in England and Wales, 2013. Euro Surveill 18(9)
Jannett FJ, Broschart MR, Grim LH, Schaberl JP (2007) Northerly range extensions of mammalian species in Minnesota. Am Midl Nat 158(1):168–176
Jimenez JE, Feinsinger P, Jaksic FM (1992) Spatiotemporal patterns of an irruption and decline of small mammals in northcentral Chile. J Mammal 173:356–364
Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, Peters CJ, Nichol ST (1997) Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 238(1):115–127
Johnson AM, De Souza LTM, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, Peters CJ, Nichol ST (1999) Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol 59:527–535
Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P (2008) Global trends in emerging infectious diseases. Nature 451(7181):990–993
Kallio ER, Klingstrom J, Gustafsson E, Manni T, Vaheri A, Henttonen H, Vapalahti O, Lundkvist A (2006) Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol 87:2127–2134
Kallio ER, Voutilainen L, Vapalahti O, Vaheri A, Henttonen H, Koskela E, Mappes T (2007) Endemic hantavirus infection impairs the winter survival of its rodent host. Ecology 88(8):1911–1916
Kallio ER, Begon M, Henttonen H, Koskela E, Mappes T, Vaheri A, Vapalahti O (2009) Cyclic hantavirus epidemics in humans–predicted by rodent host dynamics. Epidemics 1(2):101–107
Kariwa H, Kimura M, Yoshizumi S, Arikawa J, Yoshimatsu K, Takashima I, Hashimoto N (1996) Modes of Seoul virus infections: persistency in newborn rats and transiency in adult rats. Arch Virol 141(12):2327–2338
Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA (2004) Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172(5):3297–3304
Klempa B (2009) Hantaviruses and climate change. Clin Microbiol Infect 15(6):518–523
Klempa B, Schmidt HA, Ulrich R, Kaluz S, Labuda M, Meisel H, Hjelle B, Kruger DH (2003) Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature. J Virol 77(1):804–809
Klempa B, Stanko M, Labuda M, Ulrich R, Meisel H, Kruger DH (2005) Central European Dobrava hantavirus isolate from striped field mouse, Apodemus agrarius. J Clin Microbiol 43:2756–2763
Klempa B, Tkachenko EA, Dzagurova TK, Yunicheva YV, Morozov VG, Okulova NM, Slyusareva GP, Smirnov A, Kruger DH (2008) Hemorrhagic fever with renal syndrome cause by 2 lineages of Dobrava hantavirus, Russia. Emerg Infect Dis 14(4):617–625
Klempa B, Koivogui L, Sylla O, Koulemou K, Auste B, Kruger DH, Ter Meulen J (2010) Serological evidence of human hantavirus infections in Guinea, West Africa. J Infect Dis 201(7):1031–1034
Klempa B, Avsic-Zupanc T, Clement J, Dzagurova TK, Henttonen H, Heyman P, Jakab F, Kruger DH, Maes P, Papa A et al (2013) Complex evolution and epidemiology of Dobrava-Belgrade hantavirus: definition of genotypes and their characteristics. Arch Virol 158(3):521–529
Koster FT, Jenison SA (1997) Hantaviruses. In: Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases. Saunders, Philadelphia
Kraus AA, Priemer C, Heider H, Kruger DH, Ulrich R (2005) Inactivation of Hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities. Intervirology 48(4):255–261
Ksiazek T, Peters CJ, Rollin P, Zaki S, Nichol S, Spiropoulou C (1995) Identification of a new North American hantavirus that causes acute pulmonary insuffieiency. Am J Trop Med Hyg 52:117–123
Ksiazek TG, Nichol ST, Mills JN, Groves MG, Wozniak A, Mcadams S, Monroe MC, Johnson AM, Martin ML, Peters CJ et al (1997) Isolation, genetic diversity, and geographic distribution of Bayou virus (Bunyaviridae: Hantavirus). Am J Trop Med Hyg 57(4):445–448
Lederer S, Lattwein E, Hanke M, Sonnenberg K, Stoecker W, Lundkvist A, Vaheri A, Vapalahti O, Chan PK, Feldmann H et al (2013) Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. PLoS Negl Trop Dis 7(4):e2157
Leduc JW (1987) Epidemiology of Hantaan and related viruses. Lab Anim Sci 37:413–418
Leduc JW, Smith GA, Childs JE, Pinheiro FP, Maiztegui JI, Niklasson B, Antoniades A, Robinson DM, Khin M, Shortridge KF (1986) Global survey of antibody to Hantaan-related viruses among peridomestic rodents. Bull World Health Organ 64:139–144
Lee HW, Lee PW, Tamura M, Tamura T, Oku-no Y (1979) Etiological relation between Korean hemorrhagic fever and epidemic hemorrhagic fever in Japan. Biken J 22:41–45
Lee HW, Lee PW, Johnson KM (1978b) Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis 137:298–308
Lee HW, Bark DH, Baek LJ, Choi KS, Whang YN, Woo MS (1980) Korean hemorrhagic fever patients in urban areas of Seoul. Korean J Virol 10:1–6
Lee HW, French GR, Lee PW, Baek LJ, Tsuchiya K, Foulke RS (1981a) Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever. Am J Trop Med Hyg 30(2):477–482
Lee HW, Lee PW, Baek LJ, Song CK, Seong IW (1981b) Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am J Trop Med Hyg 30:1106–1112
Lee HW, Baek LJ, Johnson KM (1982) Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis 146:638–644
Lee HW, Ahn CN, Song JW, Baek LJ, Seo TJ, Park SC (1990) Field trial of an inactivated vaccine against hemorrhagic fever with renal syndrome. Arch Virol (Suppl 1):35–47
Levis S, Morzunov SP, Rowe JE, Enría D, Pini N, Calderón GE, Sabattini M, Jeor SC (1998) Genetic diversity and epidemiology of hantaviruses in Argentina. J Infect Dis 177(3):529–538
Liang M, Li D, Xiao SY, Hang C, Rossi CA, Schmaljohn CS (1994) Antigenic and molecular characterization of hantavirus isolates from China. Virus Res 31:219–233
Lin XD, Wang W, Guo WP, Zhang XH, Xing JG, Chen SZ, Li MH, Chen Y, Xu J, Plyusnin A et al (2012) Cross-species transmission in the speciation of the currently known murinae-associated hantaviruses. J Virol 86(20):11171–11182
Linderholm M, Sandstrom T, Rinnstrom O, Groth S, Blomberg A, Tarnvik A (1997) Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis 25(5):1084–1089
Liu PQ, Liao HX, Fu JL, Hang CS, Song G (1984) Isolation of epidemic hemorrhagic fever virus from Rattus losea and Rattus confucianus and their antigenic identification. Bull Jiangxi Med Coll 3:1–7
Lokugamage K, Kariwa H, Lokugamage N, Miyamoto H, Iwasa M, Hagiya T, Araki K, Tachi A, Mizutani T, Yoshimatsu K et al (2004) Genetic and antigenic characterization of the Amur virus associated with hemorrhagic fever with renal syndrome. Virus Res 101(2):127–134
Lopez N, Padula P, Rossi C, Lazaro ME, Franze-Fernandez MT (1996) Genetic identification of a new hantavirus causing severe pulmonary syndrome. Virology 220:223–226
Luis AD, Douglass RJ, Hudson PJ, Mills JN, Bjornstad ON (2012) Sin Nombre hantavirus decreases survival of male deer mice. Oecologia 169(2):431–439
Lundkvist A, Verner-Carlsson J, Plyusnina A, Forslund L, Feinstein R, Plyusnin A (2013) Pet rat harbouring Seoul hantavirus in Sweden. Euro Surveill 18(27):pii = 20521. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20521
Makela S, Mustonen J, La-Houhala I, Hurme M, Partanen J, Vapalahti O, Vaheri A, Pasternack A (2002) Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(−308) G/A polymorphism. J Infect Dis 186(6):843–846
Makela S, Kokkonen L, La-Houhala I, Groundstroem K, Harmoinen A, Huhtala H, Hurme M, Paakkala A, Porsti I, Virtanen V et al (2009) More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis 41(1):57–62
Martin ML, Lindsey Regnery H, Sasso DR, Mccormick JB, Palmer E (1985) Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy. Arch Virol 86:17–28
Matheus S, Djossou F, Moua D, Bourbigot AM, Hommel D, Lacoste V, Dussart P, Lavergne A (2010) Hantavirus pulmonary syndrome, French Guiana. Emerg Infect Dis 16(4):739–741
Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA (2006) Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis 19(5):437–442
Mills JN (2005) Regulation of rodent-borne viruses in the natural host: implications for human disease. Arch Virol 19:45–57
Mills JN (2006) Biodiversity loss and emerging infectious disease: an example from the rodent-borne hemorrhagic fevers. Biodiversity 7(1):9–17
Mills JN, Ksiazek TG, Ellis BA, Rollin PE, Nichol ST, Yates TL, Gannon WL, Levy CE, Engelthaler DM, Davis T et al (1997) Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg 56(3):273–284
Mills JN, Johnson JM, Ksiazek TG, Ellis BA, Rollin PE, Yates TL, Mann MO, Johnson RM, Campbell ML, Miyashiro J et al (1998) A survey of hantavirus antibody in small-mammal populations in selected U.S. National Parks. Am J Trop Med Hyg 58(4):525–532
Mills JN, Ksiazek TG, Peters CJ, Childs JE (1999) Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis 5(1):135–142
Mills JN, Ellis BA, Calderón G, Enría DA, Siazek TG (2007) A longitudinal study of hantavirus infection in three sympatric reservoir species in agroecosystems on the Argentina Pampa. Vector Born Zoon Dis 7:229–240
Monroe MC, Morzunov SP, Johnson AM, Bowen MD, Artsob H, Yates T, Peters CJ, Rollin PE, Ksiazek TG, Nichol ST (1999) Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis 5(1):75–86
Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA (1999) High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179(2):295–302
Moritz C, Patton JL, Conroy CJ, Parra JL, White GC, Beissinger SR (2008) Impact of a century of climate change on small-mammal communities in Yosemite National Park, USA. Science 322(5899):261–264
Muranyi W, Bahr U, Zeier M, Van Der Woude FJ (2005) Hantavirus infection. J Am Soc Nephrol 16(12):3669–3679
Mustonen J, Partanen J, Kanerva M, Pietila K, Vapalahti O, Pasternack A, Vaheri N (1996) Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 49(1):217–221
Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs JE, Zaki S, Peters CJ (1993) Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914–917
Oktem IMA, Uyar Y, Dincer E, Gozalan A, Schlegel M, Babur C, Celebi B, Sozen M, Karatis A et al (2014) Dobrava-Belgrade virus in Apodemus flavicollis and A. uralensis mice, Turkey. Emerg Infect Dis 20:121–130
Olsson GE, White N, Ahlm C, Elgh F, Verlemyr AC, Juto P, Palo RT (2002) Demographic factors associated with hantavirus infection in bank voles (Clethrionomys glareolus). Emerg Infect Dis 8(9):924–929
Olsson GE, White N, Hjalten J, Ahlm C (2005) Habitat factors associated with bank voles (Clethrionomys glareolus) and concomitant hantavirus in northern Sweden. Vector Borne Zoonotic Dis 5(4):315–323
Olsson GE, Hjertqvist M, Lundkvist A, Hornfeldt B (2009) Predicting high risk for human hantavirus infections, Sweden. Emerg Infect Dis 15(1):104–106
Olsson GE, Leirs H, Henttonen H (2010) Hantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? Vector Borne Zoon Dis 10(6):549–561
Ostfeld RS, Keesing F (2000) The function of biodiversity in the ecology of vector-borne zoonotic diseases. Can J Zool 78(2061):2078
Padula PJ, Edelstein A, Miguel SDL, Lopez NM, Rossi CM, Rabinovich RD (1998) Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241:323–330
Padula PJ, Rossi CM, La Valle MO, Martinez PV, Colavecchia SB, Edelstein A, Miguel SD, Rabinovich RD, Segura EL (2000) Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol 49(2):149–155
Padula P, La Valle MG, Alai MG, Cortada P, Villagra M, Gianella A (2002) Andes virus and first case report of Bermejo virus causing fatal pulmonary syndrome. Emerg Infect Dis 8(4):437–439
Palma RE, Polop JJ, Owen RD, Mills JN (2012) Ecology of rodent-associated hantaviruses in the Southern Cone of South America: Argentina, Chile, Paraguay, and Uruguay. J Wildl Dis 48(2):267–281
Pattamadilok S, Lee BH, Kumperasart S, Yoshimatsu K, Okumura M, Nakamura I, Araki K, Khoprasert Y, Dangsupa P, Panlar P et al (2006) Geographical distribution of hantaviruses in Thailand and potential human health significance of Thailand virus. Am J Trop Med Hyg 75(5):994–1002
Peters CM (1997) Sustainable use of biodiversity: myths, realities, and potential. In: Grifo F, Rosenthal J (eds) Biodiversity and human health. Island Press, Washington DC, pp 312–333
Peters CJ, Simpson GL, Levy H (1999) Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 50:531–545
Plyusnin A (2002) Genetics of hantaviruses: implications to taxonomy. Arch Virol 147:665–682
Plyusnin A, Vapalahti O, Vasilenko V, Henttonen H, Vaheri A (1997) Dobrava virus in Estonia: does the virus exist throughout Europe? Lancet 349:1369–1370
Plyusnin A, Nemirov K, Apekina N, Plyusnina A, Lunkdvist Å, Vaheri A (1999) Dobrava hantavirus in Russia. Lancet 353:207
Plyusnin A, Vaheri A, Lundkvist A (2006) Saaremaa hantavirus should not be confused with its dangerous relative, Dobrava virus. J Clin Microbiol 44(4):1608–1611
Plyusnin A, Ibrahim IN, Plyusnin A (2009) A newly recognized hantavirus in the Asian house rat (Rattus tanezumi) in Indonesia. J Gen Virol 90(Pt 1):205–209
Ramsden C, Holmes EC, Charleston MA (2009) Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence. Mol Biol Evol 26:143–153
Razzauti M, Plyusnina A, Sironen T, Henttonen H, Plyusnin A (2009) Analysis of Puumala hantavirus in a bank vole population in northern Finland: evidence for co-circulation of two genetic lineages and frequent reassortment between strains. J Gen Virol 90(Pt 8):1923–1931
Rivera PC, Ittig REG, Fraire HJR, Levis S, Gardenal CN (2007) Molecular identification and phylogenetic relationships among the species of the genus Oligoryzomys (Rodentia, Cricetidae) present in Argentina, putative reservoirs of hantaviruses. Zool Scr 36(3):231–239
Rodriguez LL, Owens JH, Peters CJ, Nichol ST (1998) Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology 242:99–106
Rollin PE, Ksiazek TG, Elliott LH, Ravkov EV, Martin ML, Morzunov S, Livingstone W, Monroe M, Glass G, Ruo S et al (1995) Isolation of Black Creek Canal virus, a new hantavirus from Sigmodon hispidus in Florida. J Med Virol 46(1):35–39
Root TL, Schneider SH (2002) Climate change: overview and implications for wildlife. In: Schneider SH, Root TL (eds) Wildlife responses to climate change. Island Press, Washington DC, pp 1–56
Ruedas LA, Salazar-Bravo J, Tinnin DS, Armien B, Caceres L, Garcia A, Diaz MA, Gracia F, Suzan G, Peters CJ et al (2004) Community ecology of small mammal populations in Panama following an outbreak of hantavirus pulmonary syndrome. J Vector Ecol 29(1):177–191
Salazar-Bravo J, Armién B, Suzán G, Armién A, Ruedas L, Avila M, Zaldívar Y, Pascale JM, Gracia F, Yates TL (2004) Serosurveyof wild rodents for hantaviruses in Panama, 2000–2002. J Wildl Dis 40:103–109
Sauvage F, Langlais M, Pontier D (2007) Predicting the emergence of human hantavirus disease using a combination of viral dynamics and rodent demographic patterns. Epidemiol Infect 135(1):46–56
Schmaljohn CS, Dalrymple JM (1983) Analysis of Hantaan virus RNA: evidence for a new genus of Bunyaviridae. Virology 131:482–491
Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem. Emerg Infect Dis 3:97–103
Schmaljohn CS, Hasty SE, Harrison SA, Dalrymple JM (1983) Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J Infect Dis 148:1005–1012
Schmaljohn CS, Hasty SE, Dalrymple JM, Leduc JW, Lee HW, Von Bonsdorff CH, Brummer-Korvenkontio M, Vaheri A, Tsai TF, Regnery HL et al (1985) Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227:1041–1044
Schmaljohn CS, Jennings GB, Hay J, Dalrymple JM (1986) Coding strategy of the S genome segment of Hantaan virus. Virology 155:633–643
Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM (1990) Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64:3162–3170
Schmaljohn C, Huggins J, Calisher CH (1998) Laboratory and field safety (Chapter XII) In: Lee HW, Calisher CH, Schmaljohn C (eds) Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. WHO Collaborating Center for Virus Reference and Research, Asan Institute for Life Sciences, Seoul, Korea, pp 191–198
Schountz T, Prescott J, Cogswell AC, Oko L, Mirowsky-Garcia K, Galvez AP, Hjelle B (2007) Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci U S A 104(39):15496–15501
Schwarz AC, Ranft U, Piechotowski I, Childs JE, Brockmann SO (2009) Risk factors for human infection with Puumala virus, southwestern Germany. Emerg Infect Dis 15(7):1032–1039
Sibold C, Meisel H, Lunkdvist Å, Cifire F, Ulrich R, Kozuch O, Labuda M, Kruger DH (1999) Simultaneous occurrence of Dobrava, Puumala, and Tula hantaviruses in Slovakia. Am J Trop Med Hyg 61:409–411
Sibold C, Ulrich R, Labuda M, Lundkvist Å, Schütt M, Gerke P, Leitmeyer K, Meisel H, Kruger DH (2001) Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J Med Virol 63:158–167
Sirotin BZ, Keiser NP (2001) On the history of the study of haemorrhagic fever with renal syndrome in eastern Russia. Nephrol Dial Transplant 16(6):1288–1290
Sohn YM, Rho HO, Park MS, Kim JS, Summers PL (2001) Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea. Yonsei Med J 42(3):278–284
Song G (1999) Epidemiological progresses of hemorrhagic fever with renal syndrome in China. Chin Med J 112(5):472–477
Song JW, Baek LJ, Nagle JW, Schlitter D, Yanagihara R (1996) Genetic and phylogenetic analyses of hantaviral sequences amplified from archival tissues of deer mice (Peromyscus maniculatus nubiterrae) captured in the eastern United States. Arch Virol 141(5):959–967
Song KJ, Baek LJ, Moon S, Ha SJ, Kim SH, Park KS, Klein TA, Sames W, Kim HC, Lee JS et al (2007) Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. J Gen Virol 88(Pt 11):3121–3129
Stocker TF, Qin D (2013) Climate change 2013: the physical science basis. In: Working Group I Contribution to the fifth assessment report of the intergovernmental panel on climate change: summary for policymakers. http://www.ipcc.ch/report/ar5/wg1/docs/WGIAR5_SPM_brochure_en.pdf
Suzan G, Marce E, Giermakowski JT, Mills JN, Ceballos G, Ostfeld RS, Armien B, Pascale JM, Yates TL (2009) Experimental evidence for reduced rodent diversity causing increased hantavirus prevalence. PLoS One 4(5):e5461
Suzuki A, Bisordi I, Levis S, Garcia J, Pereira LE, Souza RP, Sugahara TKN, Pini N, Enría D, Souza LTM (2004) Identifying rodent hantavirus reservoirs. Brazil Emerg Infect Dis 10(12):2127–2134
Taller AM, Xiao SY, Godec MS, Gligic A, Vsic-Zupanc T, Goldfarb LG, Asher DM (1993) Belgrade virus, a cause of hemorrhagic fever with renal syndrome in the Balkans, is closely related to Dobrava virus of field mice. J Infect Dis 168:750–753
Terajima M, Vapalahti O, Van Epps HL, Vaheri A, Ennis FA (2004) Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect 6(2):238–245
Terajima M, Hayasaka D, Maeda K, Ennis FA (2007) Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Lett 113(2):117–120
Tersago K, Verhagen R, Servais A, Heyman P, Ducoffre G, Leirs H (2009) Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate. Epidemiol Infect 137(2):250–256
Tersago K, Crespin L, Verhagen R, Leirs H (2012) Impact of Puumala virus infection on maturation and survival in bank voles: a capture-mark-recapture analysis. J Wildl Dis 48(1):148–156
Toro J, Vega JD, Khan AS, Mills JN, Padula P, Terry W, Yadon Z, Valderrama R, Ellis BA, Pavletic C et al (1998) An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 4(4):687–694
Torres-Pérez F, Navarrete-Droguett J, Aldunate R, Yates TL, Mertz GJ, Vial PA, Ferres M, Marquet PA, Palma RE (2004) Peridomestic small mammals associated with confirmed cases of human hantavirus disease on southcentral Chile. Am J Trop Med Hyg 70:305–309
Torres-Pérez F, Palma RE, Hjelle B, Ferrés M, Cook JA (2010) Andes virus infections in the rodent reservoir and in humans vary across contrasting landscapes in Chile. Infect Genet Evol 10:820–825
Travassos Da Rosa ES, Mills JN, Padula PJ, Elkhoury MR, Ksiazek TG, Mendes WS, Santos ED, Aruojo GC, Martinez VP, Edelstein A (2005) Newly recognized hantaviruses associated with hantavirus pulmonary syndrome in northern Brazil: Partial genetic characterization of viruses and serologic implication of likely reservoirs. Vector-Borne Zoon Dis 5(1):11–19
Travassos Da Rosa ES, Medeiros DB, Nunes MR, Simith DB, De Souza PA, Elkhoury MR, Lavocat M, Marques AA, Via AV, D’andrea P et al (2011) Pygmy rice rat as potential host of Castelo dos Sonhos Hantavirus. Emerg Infect Dis 17(8):1527–1530
Umenai T, Lee PW, Toyoda T, Yoshinaga K, Horiuchi T, Lee HW, Saito T, Hongo M, Nobo-naga T, Ishida N (1979) Korean hemorrhagic fever in an animal laboratory. Lancet 1(8130):1314–1316
Vaheri A, Mills JN, Christina F, Spiropoulou F, Hjelle B (2011) Hantaviruses. In: Palmer SR, Soulsby L, Torgerson T, Brown DWG (eds) Oxford textbook of zoonoses. Oxford University Press, Oxford, pp 307–322 (Chap. 28 Fig. 28.2)
Vaheri A, Henttonen H, Voutilainen L, Mustonen J, Sironen T, Vapalahti O (2013) Hantavirus infections in Europe and their impact on public health. Rev Med Virol 23(1):35–49
Vapalahti O, Lundkvist A, Kukkonen SKJ, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A et al (1996) Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 77(Pt 12):3063–3067
Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A (2003) Hantavirus infections in Europe. Lancet Infect Dis 3(10):653–661
Vincent MJ, Quiroz E, Gracias F, Sanchez A, Ksiazek T, Kitzutani P, Ruedas LA, Tinnin D, Caceres L, Garcia A et al (2000) Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology 277:14–19
Wang H, Yoshimatsu K, Ebihara H, Ogino M, Araki K, Kariwa H, Wang Z, Luo Z, Li D, Hang C et al (2000) Genetic diversity of hantaviruses isolated in China and characterization of novel hantaviruses isolated from Niviventer confucianus and Rattus rattus. Virology 278(2):332–345
Wilson DE, Reeder DM (2005) Mammal species of the world. Johns Hopkins University Press, Baltimore
Wolfe ND, Daszak P, Kilpatrick AM, Burke DS (2005) Bushmeat hunting, deforestation, and prediction of zoonoses emergence. Emerg Infect Dis 11:1822–1827
Wright HE, Kutzbach JE, Webb T, Ruddiman WE, Street-Perrott FA, Bartlein PJ (1993) Global climates since the last glacial maximum. University of Minnesota Press, Minneapolis
Xiao SY, Diglisic G, Vsic-Zupanc T, Leduc JW (1993) Dobrava virus as a new Hantavirus: evidenced by comparative sequence analysis. J Med Virol 39:152–155
Xu ZY, Gou CS, Wu YL, Zhang XW, Liu K (1985) Epidemiological studies of hemorrhagic fever with renal syndrome: analysis of risk factors and of transmission. J Infect Dis 152:137–144
Yan L, Fang LQ, Huang HG, Zhang LQ, Feng D, Zhao WJ, Zhang WY, Li XW, Cao WC (2007) Landscape elements and Hantaan virus-related hemorrhagic fever with renal syndrome, People’s Republic of China. Emerg Infect Dis 13(9):1301–1306
Yashina LN, Patrushev NA, Ivanov LI, Slonova RA, Mishin VP, Kompanez GG, Zdanovskaya NI, Kuzina II, Safronov PF, Chizhikov VE et al (2000) Genetic diversity of hantaviruses associated with hemorrhagic fever with renal syndrome in the far east of Russia. Virus Res 70(1–2):31–44
Yates TL, Mills JN, Parmenter CA, Ksiazek TG, Parmenter RR, Vande Castle JR, Calisher CH, Nichol ST, Abbott KD, Young JC et al (2002) The ecology and evolutionary history of an emergent disease: hantavirus pulmonary syndrome. Bioscience 52(11):989–998
Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS et al (1995) Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 146:552–579
Zhang YZ, Zou Y, Yao LS, Hu GW, Du ZS, Jin LZ, Liu YY, Wang HX, Chen X, Chen HX et al (2007) Isolation and characterization of hantavirus carried by Apodemus peninsulae in Jilin, China. J Gen Virol 88(Pt 4):1295–1301
Zhang YZ, Zou Y, Fu ZF, Plyusnin A (2010) Hantavirus infections in humans and animals, China. Emerg Infect Dis 16(8):1195–1203
Zou Y, Hu J, Wang ZX, Wang DM, Yu C, Zhou JZ, Fu ZF, Zhang YZ (2008) Genetic characterization of hantaviruses isolated from Guizhou, China: evidence for spillover and reassortment in nature. J Med Virol 80(6):1033–1041
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Yuill, T.M., Mills, J.N. (2014). Hantaviruses. In: Yamada, A., Kahn, L., Kaplan, B., Monath, T., Woodall, J., Conti, L. (eds) Confronting Emerging Zoonoses. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55120-1_4
Download citation
DOI: https://doi.org/10.1007/978-4-431-55120-1_4
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55119-5
Online ISBN: 978-4-431-55120-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)